BridgeMD
New treatment option for Peanut Allergy
Official title Immune-supportive Diet and Gut Permeability in Allergic Children
ClinicalTrials.gov ID: NCT05667610
What this study is testing
- What it's testing
- Peanut and nut allergy can be life threatening. Some patients have very low threshold levels (i.e.
- You might receive a placebo (an inactive treatment) instead of the study drug. You may not know which one you got.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 3 to 17. Healthy volunteers may be eligible.
You may be able to join if
- Children of 3 to 17 years of age with a positive open or blinded compared with an inactive treatment peanut or nut challenge \< 12 months to...
- Children who are potty trained or house trained;
- Presence of IgE to peanut ≥0.35 kilo units per liter (kU/l) or skin prick test \> 3 mm to peanut or nut, \< 12 months prior to challenge.
You likely can't join if
- Only mild symptoms in the oral cavity to peanut or nut due to pollen food syndrome;
- A negative peanut or nut challenge;
- Children who are not potty trained (house trained);
- Gastro-intestinal diseases (e.g. Morbus Crohn, coeliac disease, Colitis Ulcerosa), lactose intolerance
- severe cow's milk allergy -because of possible traces of cow's milk in lactose in the SAT), syndromes, infectious/immunology diseases other than...
- Laxative treatment, such as lactulose;
See the full eligibility criteria
- Children of 3 to 17 years of age with a positive open or blinded compared with an inactive treatment peanut or nut challenge \< 12 months to inclusion OR an obvious and objective IgE-mediated allergic reaction following...
- Children who are potty trained or house trained;
- Presence of IgE to peanut ≥0.35 kilo units per liter (kU/l) or skin prick test \> 3 mm to peanut or nut, \< 12 months prior to challenge.
- Only mild symptoms in the oral cavity to peanut or nut due to pollen food syndrome;
- A negative peanut or nut challenge;
- Children who are not potty trained (house trained);
- Gastro-intestinal diseases (e.g. Morbus Crohn, coeliac disease, Colitis Ulcerosa), lactose intolerance
- severe cow's milk allergy -because of possible traces of cow's milk in lactose in the SAT), syndromes, infectious/immunology diseases other than atopy, or diabetes;
- Laxative treatment, such as lactulose;
- Not able to read or write Dutch.
The study team makes the final eligibility decision.
Where it's taking place
- Amsterdam, Netherlands
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 3 years to 17 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Amsterdam, Netherlands. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.